Center for Health Equity Research receives $1.2 million for projects related to COVID-19
Virtual Reality health appointments can help patients address eating disorders
Peak Optimism? S&P Futures Hit After Too Much "Stimulus Optimism" Sends 10Y Yields Surging
Xeris Wins FDA Fast Track Path For Epilepsy Treatment; Shares Spike 9%
D3Targets-2019-nCoV: a webserver for predicting drug targets and for target and multi-site based virtual screening against COVID-19
Kamada To Supply Plasma-Based Covid-19 Therapy To Israel; Shares Surge 6%
These 3 Penny Stocks Have Massive Upside Potential, Says Cowen
Medicare Q&A with Aetna’s Christopher Ciano.
AstraZeneca Gets EU Recommendations For Heart Failure, Lung Treatments
7 tips for staying safe as COVID-19 cases rise and colder weather heightens the risk
How real human experiences can power a healthier future
Goldman Sachs: 2 Stocks That Could Climb Over 90%
Eli Lilly To Snap Up Disarm In $135M Deal; Street Stays Bullish
Halted Trials Raise New Safety Questions About 'Rushed' COVID-19 Vaccines
Canaccord Predicts Over 100% Rally for These 3 “Strong Buy” Stocks
Lineage tracing of direct astrocyte-to-neuron conversion for brain repair
FDA officials, experts discuss impact of Covid-19 on cell and gene therapies
Venezuela's COVID-19 Battle Is Badly Hamstrung By The 31 Tons Of Gold Stolen From Its Treasury
Entos launches US-based spinout Aegis Life, Inc. to support its global vaccine strategy
To build back better after COVID-19, we must support parents
Army researchers collaborate on universal antibody test for COVID-19
Raymond James Says These 3 Stocks Could Surge Over 100% From Current Levels
Bill Gates Warns "World Won't Return To Normal" Until "Second Generation" Of COVID-19 Super-Vaccines Arrives
Lilly pauses COVID-19 antibody trial after factory hits trouble with FDA
NIH study aims to identify promising COVID-19 treatments for larger clinical trials
News briefing: Regeneron/Sanofi post positive PhIII Dupixent data in pediatric asthma; Vineti scores $33M Series C extension
Proactivity and partnership pay off for nursing homes in a pandemic, study suggests
Sorrento Adds Stem Cell Treatment To Covid-19 Pipeline; Shares Rise
Takeda group begins manufacturing Covid-19 plasma treatment ahead of approval
Covid-19 antibodies last at least three months; so do symptoms for many